Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Hasumura, Takahiro ^a   Shimada, Yasuhito ^b,c,d   Kuroyanagi, Junya ^b   Nishimura, Yuhei ^b,c,d   Meguro, Shinichi ^a   Takema, Yoshinori ^a   Tanaka, Toshio ^b,c,d  

^a KAO CORPORATION   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MIE UNIVERSITY   (Japan)

^d MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3D micro computed tomography; Body fat; Catechin; Diet induced obesity; Green tea extract; SOCS3; Zebrafish

Indexed keywords

GREEN TEA EXTRACT; LEPTIN;

ACYLCOENZYME A DEHYDROGENASE,C 4 TO C 12 STRAIGHT CHAIN GENE; ACYLCOENZYME A OXIDASE 1, PALMITOYL GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTEMIA; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CONTROLLED STUDY; DIET; FEMALE; FERTILIZATION; FOOD INTAKE; GENE; GENE EXPRESSION; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA GENE; SUBCUTANEOUS FAT; SUPPRESSOR OF CYTOKINE SIGNALING 3B GENE; ZEBRA FISH;

ARTEMIA; DANIO RERIO; MAMMALIA;

EID: 84864765761     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-73     Document Type: Article

References (50)

1. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Malik VS, Popkin BM, Bray GA, Després JP, Hu FB, Circulation 2010 121 1356 1364 10.1161/CIRCULATIONAHA.109.876185 20308626
2. Obesity and the regulation of energy balance. Spiegelman BM, Flier JS, Cell 2001 104 531 543 10.1016/S0092-8674(01)00240-9 11239410 (Pubitemid 32201948)
3. Subcutaneous and visceral adipose tissue: structural and functional differences. Ibrahim MM, Obes Rev 2010 11 11 18 10.1111/j.1467-789X.2009.00623.x 19656312
4. Visceral fat is an independent predictor of all-cause mortality in men. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R, Obesity 2006 14 336 341 10.1038/oby.2006.43 16571861 (Pubitemid 46214766)
5. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Rice-Evans CA, Miller NJ, Paganga G, Free Rad Biol Med 1996 20 933 956 10.1016/0891-5849(95)02227-9 8743980 (Pubitemid 26157509)
6. Green tea polyphenols: biology and therapeutic implications in cancer. Shankar S, Ganapathy S, Srivastava RK, Front Biosci 2007 12 4881 4899 10.2741/2435 17569617
7. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Zaveri NT, Life Sci 2006 78 2073 2080 10.1016/j.lfs.2005.12.006 16445946
8. Reduction of blood glucose levels by tea catechin. Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y, Biosci. Biotechnol. Biochem 1993 57 525 527 10.1271/bbb.57.525
9. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T, J. Nutr 2001 131 27 32 11208934 (Pubitemid 32060618)
10. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Klaus S, Pultz S, Thone-Reineke C, Wolfram S, Int J Obes 2005 29 615 623 10.1038/sj.ijo.0802926 (Pubitemid 40769483)
11. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I, Int J Obes 2002 26 1459 1464 10.1038/sj.ijo.0802141 (Pubitemid 36005776)
12. Effect of intake of a beverage containing 540 mg catechins on the body composition of obese women and men. Kozuma K, Chikama A, Hoshino E, Kataoka K, Mori K, Hase T, Katsuragi Y, Tokimitsu I, Nakamura H, Prog Med 2005 25 1945 1957
13. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I, Am J Clin Nutr 2005 81 122 129 15640470 (Pubitemid 43073384)
14. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Nagao T, Hase T, Tokimitsu I, Obesity 2007 15 1473 1483 10.1038/oby.2007.176 17557985 (Pubitemid 47110911)
15. Effects of long-term ingestion of tea catechins on visceral fat accumulation and metabolic syndrome: pooling-analysis of 7 randomized controlled trials. Takase H, Nagao T, Otsuka K, Kozuma K, Kataoka K, Meguro S, Komikado M, Tokimitsu I, Jpn Pharmacol Ther 2008 36 509 514
16. Effects of long-term consumption of tea catechins-enriched beverage with no caffeine on body composition in humans. Takeshita M, Takashima S, Harada U, Shibata E, Hosoya N, Takase H, Otsuka K, Meguro S, Komikado M, Tokimitsu I, Jpn Pharmacol Ther 2008 36 767 776
17. Effects of catechin-enriched green tea beverage on visceral fat loss in adults with a high proportion of visceral fat: a double-blind, placebo-controlled, randomized trial. Zhang Y, Yu Y, Li X, Meguro S, Hayashi S, Katashima M, Yasumasu T, Wang J, Li K, J Funct Foods 2012 4 315 322 10.1016/j.jff.2011.12.010
18. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J, Am J Clin Nutr 1999 70 1040 1045 10584049
19. Exercise and green tea extract stimulate fat oxidation and prevent obesity in mice. Shimotoyodome A, Haramizu S, Inaba M, Murase T, Tokimitsu I, Med Sci Sports Exerc 2005 37 1884 1892 10.1249/01.mss.0000178062.66981.a8 16286857 (Pubitemid 41691830)
20. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3 T3-L1 cells. Furuyashiki T, Nagayasu H, Aoki Y, Bessho H, Hashimoto T, Kanazawa K, Ashida H, Biosci Biotech Biochem 2004 68 2353 2359 10.1271/bbb.68.2353 (Pubitemid 40033512)
21. Dietary gallate esters of tea catechins reduce deposition of visceral fat, hepatic triacylglycerol, and activities of hepatic enzymes related to fatty acid synthesis in rats. Ikeda I, Hamamoto R, Uzu K, Imaizumi K, Nagao K, Yanagita T, Suzuki Y, Kobayashi M, Kakuda T, Biosci Biotech Biochem 2005 69 1049 1053 10.1271/bbb.69.1049 (Pubitemid 41006986)
22. Isolation and identification of acetyl-CoA carboxylase inhibitors from green tea (Camellia sinensis). Watanabe J, Kawabata J, Niki R, Biosci Biotechnol Biochem 1998 62 532 534 10.1271/bbb.62.532 9571782 (Pubitemid 128474960)
23. Zebrafish: an in vivo model for the study of neurological diseases. Best JD, Alderton WK, Neuropsych Dis Treat 2008 4 567 576 (Pubitemid 352037836)
24. Zebrafish as a genetic model in biological and behavioral gerontology: where development meets aging in vertebrates - a mini-review. Kishi S, Slack BE, Uchiyama J, Zhdanova IV, Gerontology 2009 55 430 441 10.1159/000228892 19654474
25. Animal models of human disease: zebrafish swim into view. Lieschke GJ, Currie PD, Nat Rev Genet 2007 8 353 367 10.1038/nrg2091 17440532 (Pubitemid 46625809)
26. The lipid composition and biochemistry of freshwater fish. Henderson RJ, Tocher DR, Prog Lipid Res 1987 26 281 347 10.1016/0163-7827(87)90002-6 3324105
27. Zebrafish: gaining popularity in lipid research. Hölttä-Vuori M, Salo VTV, Nyberg L, Brackmann C, Enejder A, Panula P, Ikonen E, Biochem J 2010 429 235 242 10.1042/BJ20100293 20578994
28. Conserved expression of alternative splicing variants of peroxisomal acyl-CoA oxidase 1 in vertebrates and developmental and nutritional regulation in fish. Morais S, Knoll-Gellida A, André M, Barthe C, Babin PJ, Physiol Genom 2007 28 239 252 (Pubitemid 46708767)
29. Creation of a genetic model of obesity in a teleost. Song Y, Cone RD, FASEB J 2007 21 2042 2049 10.1096/fj.06-7503com 17341684 (Pubitemid 47026440)
30. Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, Hall C, Pattison J, Juliano J, Miller ER, Almazan F, Crosier P, Witztum JL, Klemke RL, Miller YI, Circ Res 2009 104 952 960 10.1161/CIRCRESAHA.108.189803 19265037
31. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z, Umemoto N, Kuroyanagi J, Nishimura N, Tanaka T, BMC Physiol 2010 10 21 10.1186/1472-6793-10-21 20961460
32. Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Tainaka T, Shimada Y, Kuroyanagi J, Zang L, Oka T, Nishimura Y, Nishimura N, Tanaka T, Nutr Metab 2011 8 88 10.1186/1743-7075-8-88
33. Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise. Murase T, Haramizu S, Shimotoyodome A, Tokimitsu I, Hase T, Am J Physiol Reg Integr Comp Physiol 2006 290 1550 R1556 10.1152/ajpregu.00752.2005 (Pubitemid 43830819)
34. Westerfield M, A guide for the laboratory use of zebrafish (Danio rerio) Eugene: University of Oregon Press 2007
35. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, Jois M, Sinclair AJ, Begg DP, Wark JD, Weisinger HS, Weisinger RS, Nutr Res 2009 29 784 793 10.1016/j.nutres.2009.10.003 19932867
36. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Lee MS, Kim CT, Kim Y, Ann Nutr Metab 2009 54 151 157 10.1159/000214834 19390166
37. Weight control and prevention of metabolic syndrome by green tea. Sae-Tan S, Grove KA, Lambert JD, Pharmacol Res 2011 64 146 154 10.1016/j.phrs.2010.12. 013 21193040
38. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. Park HJ, DiNatale DA, Chung MY, Park YK, Lee JY, Koo SI, OConnor M, Manautou JE, Bruno RS, J Nutr Biochem 2011 22 393 400 10.1016/j.jnutbio.2010.03.009 20655714
39. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. Letexier D, Pinteur C, Large V, Fréring V, Beylot M, J Lipid Res 2003 44 2127 2134 10.1194/jlr.M300235-JLR200 12897191 (Pubitemid 37509628)
40. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjoørbæk C, Flier JS, Nat Med 2004 10 734 738 10.1038/nm1072 15220914 (Pubitemid 38937639)
41. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, Bastard JP, Laville M, Vidal H, Diabetes 2004 53 2232 2241 10.2337/diabetes.53.9.2232 15331532 (Pubitemid 39145576)
42. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression. Kanatani Y, Usui I, Ishizuka K, Bukhari A, Fujisaka S, Urakaze M, Haruta T, Kishimoto T, Naka T, Kobayashi M, Diabetes 2007 56 795 803 10.2337/db06-1039 17327450 (Pubitemid 46348484)
43. Inhibition of SOCS-3 in adipocytes of rats with diet-induced obesity increases leptin-mediated fatty acid oxidation. Gu H, Liu L, Ma S, Liu Y, Ren Y, Zhai L, Yu F, An L, Yang J, Endocrine 2009 36 546 554 10.1007/s12020-009-9253-4 19862646
44. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE, Diabetologia 2003 46 459 469 12687327 (Pubitemid 36577787)
45. New criteria for obesity disease in Japan. Matsuzawa Y, Nakamura T, Takahashi M, Ryo M, Inoue S, Ikeda Y, Ohno M, Sakata T, Fukagawa K, Saitoh Y, Sato Y, Shirai K, Miyazaki S, Tokunaga K, Yamanouchi K, Takahashi M, Shibasaki T, Nagai M, Circ J 2002 66 987 992 10.1253/circj.66.987 12419927 (Pubitemid 35416333)
46. Quantification of adiposity in small rodents using micro-CT. Judex S, Luu YK, Ozcivici E, Adler B, Lublinsky S, Rubin CT, Methods 2010 50 14 19 10.1016/j.ymeth.2009.05.017 19523519
47. In vivo quantification of subcutaneous and visceral adiposity by micro-computed tomography in a small animal model. Luu YK, Lublinsky S, Ozcivici E, Capilla E, Pessin JE, Rubin CT, Judex S, Med Eng Phys 2009 31 34 41 10.1016/j.medengphy.2008.03.006 18486521
48. Rapid and non-invasive measurements of fat and pigment concentrations in live and slaughtered Atlantic salmon (Salmo salar L.). Folkestad A, Wold JP, Rørvik KA, Tschudi J, Haugholt KH, Kolstad K, Mørkøre T, Aquaculture 2008 280 129 135 10.1016/j.aquaculture.2008.04.037
49. Muscle lipid storage pattern, composition, and adipocyte distribution in different parts of Atlantic salmon (Salmo salar) fed fish oil and vegetable oil. Nanton DA, Vegusdal A, Rørå AMB, Ruyter B, Baeverfjord G, Torstensen BE, Aquaculture 2007 265 230 243 10.1016/j.aquaculture.2006.03.053 (Pubitemid 46527789)
50. Non-invasive measurement of fillet composition of four freshwater fish species by computer tomography. Romvári R, Hancz CS, Petrási ZS, Molnár T, Horn P, Aquacult Int 2002 10 231 240 10.1023/A:1022196413528 (Pubitemid 36317748)